Evidence map›Paper›PMID 40429891›Full record

ReviewInternational journal of molecular sciences2025

Next-Level Prediction of Structural Progression in Knee Osteoarthritis: A Perspective.

Johanne Martel-Pelletier, Jean-Pierre Pelletier

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Advances in molecular imaging for osteoarthritis.Connective tissue research · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Johanne Martel-PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, R11.412B, Montreal, QC H2X 0A9, Canada.ORCID 0000-0003-2618-383X
Jean-Pierre PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, R11.412B, Montreal, QC H2X 0A9, Canada.ORCID 0000-0001-9930-6453

Funding

Osteoarthritis Research Unit of the University of Montreal Hospital Research Centre, Montreal, Quebec, Canada. n/a
6 · The paper itself

Abstract

Osteoarthritis (OA) is a prevalent and disabling chronic disease, with knee OA being the most common form, affecting approximately 73% of individuals over 55 years. Traditional clinical assessments often fail to predict knee structural progression accurately, highlighting the need for improved prognostic methods. This perspective explores the complexity of stratifying knee OA patients based on rapid structural progression. It underscores the importance of such early identification to enable timely and personalized intervention and optimize disease-modifying OA drug clinical trial design, as many trial participants show minimal progression, complicating the assessment of treatment efficacy. We highlight the potential of machine learning (ML) and deep learning (DL) in overcoming this prognostic challenge, as these methodologies enhance classification/stratification capabilities by leveraging multidimensional data and capturing the intricate relationships between diverse features. These include panels of biochemical markers and imaging markers, such as those from magnetic resonance imaging (MRI), as integrating MRI data into ML/DL prognostic models enhances such prediction performance. These automated ML/DL models will offer a transformative approach to stratifying knee OA patients and represent a paradigm shift in disease management. Ultimately, ML/DL applications will not only improve patient outcomes but will also promote innovation in OA research, clinical practice, and therapeutics.

Indexed as

Osteoarthritis, KneeBiomarkersDeep LearningDisease ProgressionHumansMachine LearningMagnetic Resonance ImagingPrognosisBiomarkersbiochemical markers osteoarthritiskneemachine and deep learningmagnetic resonance imaging (MRI)osteoarthritispredictionprognosticstructural progression

Identifiers

PMID40429891
PMCPMC12112129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.